Tyrosine Kinase Inhibitors in the Treatment of Choroidal Metastases From Non-Small-Cell Lung Cancer: A Case Report and Review of Literature

Ocular Oncology and Pathology - Switzerland
doi 10.1159/000448114
Full Text
Abstract

Available in full text

Categories
Nursing
Date
Authors
Publisher

S. Karger AG

Related search

Gemcitabine Plus Oxaliplatin for the Treatment of Leptomeningeal Metastases of Non-Small Cell Lung Cancer: A Case Report and Review of the Literature

Oncology Letters
Cancer ResearchOncology
2013English

P1.01-19 Efficacy of Tyrosine Kinase Inhibitors in EGFR Mutated Non-Small Cell Lung Cancer With Leptomeningeal Metastases

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Non-Small Cell Lung Cancer-Small Cell Lung Cancer Transformation as Mechanism of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

2020English

Hypothalamic Hypopituitarism Secondary to Suprasellar Metastases From Small Cell Lung Cancer: A Case Report and Review of the Literature

Journal of Medical Case Reports
Medicine
2018English

The Treatment of Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors

2013English

Defining the Role of Tyrosine Kinase Inhibitors in Early Stage Non-Small Cell Lung Cancer

Journal of Cancer
Oncology
2015English

Quick Regression of Brain Metastases From Lung Adenocarcinoma With Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Case Report and Literature Review

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

Corrigendum: A Personalized Approach to Treatment: Use of EGFR Tyrosine Kinase Inhibitors for the Treatment of Non-Small-Cell Lung Cancer in Canada

Current Oncology
Oncology
2012English

Economic Evaluation of First Line Treatment for Advanced Non Small Cell Lung Cancer Using Tyrosine Kinase Inhibitors in Malaysia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy